Announcement
01 Dec 2025
In December 2025, the U.S. Administration announced its commitments under an agreement on pharmaceutical pricing with the United Kingdom.
Source
Number of interventions
1
0 certainly harmful
1 likely harmful
0 liberalising
Implementation date
No implementation date
Revocation date:
No revocation date
Recent update from 01 Dec 2025:
On 1 December 2025, the Office of the United States Trade Representative (USTR) announced an agreement in principle with the United Kingdom to rebalance pharmaceutical pricing and strengthen bilate...
01 Dec 2025
United Kingdom: UK Government’s commitments under an agreement on pharmaceuticals with the United States
08 May 2025
United States of America: US Administration's commitments under "Economic Prosperity Deal" with the United Kingdom
08 May 2025
United Kingdom: UK Government's commitments under "Economic Prosperity Deal" with the United States
01 Apr 2025
United States of America: Commerce Department initiates a Section 232 investigation into national security risks of pharmaceutical imports
See all
This state act is not part of any Thread yet.